Michel Detheux - Chief Executive Officer at iTeos Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer
Stock Symbol
ITOS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michel Detheux since 9/17/2023

Holdings reported by Michel Detheux for iTeos Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 58.9K $493K $8.37 Dec 5, 2023 Direct
Stock Option (Right to Buy) 443K Aug 8, 2024 By MG3A Common Stock
Stock Option (Right to Buy) 148K Aug 8, 2024 Direct Common Stock

Transactions reported by Michel Detheux for iTeos Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.